|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvalYear
|
1989
|
|
gptkbp:ATCCode
|
M01AB15
|
|
gptkbp:contraindication
|
gptkb:peptic_ulcer
renal impairment
history of GI bleeding
|
|
gptkbp:drugClass
|
gptkb:nonsteroidal_anti-inflammatory_drug
|
|
gptkbp:genericName
|
gptkb:ketorolac
|
|
gptkbp:halfLife
|
4-6 hours
|
|
gptkbp:legalStatus
|
Rx-only
|
|
gptkbp:manufacturer
|
gptkb:Roche
|
|
gptkbp:maximumDurationOfUse
|
5 days
|
|
gptkbp:mechanismOfAction
|
COX inhibitor
|
|
gptkbp:notRecommendedFor
|
chronic pain
pediatric patients under 2 years
|
|
gptkbp:pregnancyCategory
|
C (prior to 30 weeks gestation)
D (after 30 weeks gestation)
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:riskFactor
|
increased risk of cardiovascular events
increased risk of gastrointestinal bleeding
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
nausea
headache
gastrointestinal bleeding
drowsiness
renal impairment
|
|
gptkbp:usedFor
|
pain management
|
|
gptkbp:bfsParent
|
gptkb:ketorolac
|
|
gptkbp:bfsLayer
|
8
|
|
http://www.w3.org/2000/01/rdf-schema#label
|
Toradol
|